S Höcht1, T Wiegel. 1. Hermann-Holthusen-Institut für Strahlentherapie, Allgemeines Krankenhaus St. Georg, Hamburg. hoecht@ukbf.fu-berlin.de
Abstract
BACKGROUND: Despite an increasing number of reports Merkel-cell-carcinoma still is a rare neoplasm. Reports on radical radiotherapy are sparse. PATIENT AND METHOD: We report on a successful radical radiotherapy of a recurrent Merkel-cell-carcinoma of the eyelid in an 84-year old woman, using a hypofractionated treatment of 50 Gy with 70 kV-X-rays, 10 fractions of 5 Gy within 5 weeks. RESULT: Rapid and complete remission was achieved, with no signs of local or distant failure 24 months after the end of therapy. CONCLUSION: The case reported on highlights the radiosensitivity of this tumor and the role of radiotherapy not merely as salvage procedure.
BACKGROUND: Despite an increasing number of reports Merkel-cell-carcinoma still is a rare neoplasm. Reports on radical radiotherapy are sparse. PATIENT AND METHOD: We report on a successful radical radiotherapy of a recurrent Merkel-cell-carcinoma of the eyelid in an 84-year old woman, using a hypofractionated treatment of 50 Gy with 70 kV-X-rays, 10 fractions of 5 Gy within 5 weeks. RESULT: Rapid and complete remission was achieved, with no signs of local or distant failure 24 months after the end of therapy. CONCLUSION: The case reported on highlights the radiosensitivity of this tumor and the role of radiotherapy not merely as salvage procedure.
Authors: M Suntharalingam; M S Rudoltz; W M Mendenhall; J T Parsons; S P Stringer; R R Million Journal: Head Neck Date: 1995 Mar-Apr Impact factor: 3.147